Innovating.works Conecta tu I+D

TextaDNA: High-throughput oligonucleotide synthesis and NGS for Digital TEXT Storage And retrieval in DNA enca... EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 Incorporating biomolecules as integral parts of computational systems represents a frontier challenge in bio and nanotechnology. Using DNA t...
2023-10-30 - 2028-01-31 | financed

BarleyMicroBreed: Strategies for breeding climate change resilient barley, genetically equipped to optimized root-micr... EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un HORIZON EUROPE: HORIZON-CL6-2021-BIODIV-01 BarleyMicroBreed builds on the paradigm that crop resource efficiency and stress resilience can be significantly improved by optimizing the...
2022-06-09 - 2028-10-31 | financed

FORECEE: Female cancer prediction using cervical omics to individualise screening and prevention EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un H2020: H2020-PHC-2014-2015 While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significan...
2015-03-27 - 2020-02-29 | financed

CELL-PID: Advanced Cell based Therapies for the treatment of Primary ImmunoDeficiency EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: Primary immune deficiencies (PID) are inherited disorders of the adaptive and innate immune system marked by severe infections, autoimmunity...
financed

BEAN: BEAN Bridging the European and Anatolian Neolithic Demography Migration and Lifestyle at the A... EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: One of the most interesting questions in prehistory is that of the origins of European peoples following the introduction of settled farming...
financed

EURO-GENE-SCAN: European Genetic Disease Diagnostics EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: Molecular techniques have become more efficient, increasingly precise and much cheaper, resulting in an unprecedented discovery rate of inhe...
financed

HUMAN: Health and the Understanding of Metabolism Aging and Nutrition EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: Recently intense research identified around 4,000 single nucleotide polymorphisms (SNPs) associated with human age related diseases such as...
financed

SYBIL: Systems biology for the functional validation of genetic determinants of skeletal diseases EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: "The aim of SYBIL is to carry out extensive functional validation of the genetic determinants of rare and common skeletal diseases and the a...
financed

PERSIST: Persisting Transgenesis EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: For many disabling or fatal diseases, there is pre-clinical or clinical evidence of the potential therapeutic efficacy of gene therapy and,...
financed

EUROFANCOLEN: Phase I II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lent... EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: Fanconi anemia (FA) is a rare inherited syndrome characterized by the early development of bone marrow failure and increasing predisposition...
financed

NET4CGD: Gene Therapy for X linked Chronic Granulomatous Disease CGD EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: This project is focused on the clinical development of a new orphan drug that can rapidly become a new treatment option for patients with th...
financed

EPI-FEM-CARE: EPIGENETICS FOR FEMALE PERSONALIZED CANCER CARE EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: CLINICAL NEED Every year in the EU ~45,300 and 330,000 women are diagnosed with ovarian and breast cancer respectively & 28,800 and 90,000 o...
financed

SYSCLAD: Systems prediction of Chronic Lung Allograft Dysfunction EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: Lung transplantation (LT) is the standard of care for selected patients with chronic respiratory failure. Chronic lung allograft dysfunctio...
financed

TB-VIR: Mycobacterium tuberculosis W Beijing genetic diversity and differential virulence and host immune re... EUROFINS GENOMICS EUROPE PHARMA AND DIAGNOSTICS PRODUCTS SERVICES SANGER PCR GMBH participó en un FP7: Improvements in TB control require the development of new tools for rapid and accurate diagnosis and intervention. This development is likel...
financed

EUROFINS GENOMICS EUROPE PHARMA AND DIA...